MedTrace Logo

PSMA-based 18F-DCFPyL PET/CT: Evaluating Its Application in Real Life

NCT03609736 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2019-02-15

No results posted yet for this study

Summary

The purpose of the study is to provide pilot data on the clinical situations in which ordering a 18F-DCFPyL positron emission tomography/computed tomography (PET/CT) was thought to be clinically useful, and to document how the results of the 18F-DCFPyL PET/CT affected patient management. The results of this study could then serve as a guide to help OHIP to consider these scenarios when deciding the precise indications for funded 18F-DCFPyL PET/CT scans in the future. In this study the investigators will image subjects with prostate cancer using 18F-DCFPyL PET/CT and record how the result of the study affected patient management.

Conditions

Interventions

DIAGNOSTIC_TEST

18F-DCFPyL PET/CT

* A bolus of less than or equal to 9 mCi (333 MBq) of 18F-DCFPyL will be injected IV by slow IV push. * After administration of the 18F-DCFPyL the line will be flushed with saline (0.9% w/v). * Subjects should be encouraged to drink up to 500 mL of water shortly after the administration of 18F-DCFPyL. * At 60-minutes (± 10 minutes) after administration of 18F-DCFPyL, the PET/CT scan will be acquired with the subject in the supine position and the FOV including the mid-thighs to skull base.

Sponsors & Collaborators

  • St. Joseph's Healthcare Hamilton

    collaborator OTHER

  • Grand River Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-10
Primary Completion
2019-08-31
Completion
2019-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03609736 on ClinicalTrials.gov